Cutler Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,400
Closed -$5K 5745
2017
Q3
$5K Hold
9,400
﹤0.01% 4418
2017
Q2
$4K Buy
+9,400
New +$357K ﹤0.01% 5062
2017
Q1
Sell
-5,200
Closed -$6K 7052
2016
Q4
$6K Sell
5,200
-37,700
-88% -$1.17M ﹤0.01% 4777
2016
Q3
$13K Sell
42,900
-7,800
-15% -$235K ﹤0.01% 3906
2016
Q2
$43K Buy
50,700
+13,500
+36% +$345K ﹤0.01% 2516
2016
Q1
$55K Buy
37,200
+17,700
+91% +$433K ﹤0.01% 2221
2015
Q4
$14K Buy
+19,500
New +$562K ﹤0.01% 3785

Other funds holding RGEN

Cutler Group's RGEN Position: Q3 2016 in Review

Cutler Group sold out of Repligen (RGEN) in Q3 2016, closing a stake of 1,401 shares — an estimated $42.3K sold.

Cutler Group first reported a position in RGEN in Q2 2016 and held it in 1 quarter. The position peaked at $38K in Q2 2016. 181 funds tracked by Wall St. Rank hold RGEN as of Q3 2016.

  • Cutler Group reported no remaining Repligen position as of Q3 2016 after selling out during the quarter.
  • Cutler Group sold 1,401 Repligen shares in Q3 2016, an estimated $42.3K.
  • Cutler Group first reported a position in Repligen in Q2 2016 and held it in 1 quarter.
  • Cutler Group's Repligen position peaked at $38K in Q2 2016.
  • 181 funds tracked by Wall St. Rank held Repligen as of Q3 2016.

Based on Cutler Group's 13F filing for Q3 2016, filed 11 Oct 2016.